[Federal Register Volume 82, Number 102 (Tuesday, May 30, 2017)]
[Notices]
[Page 24729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-10989]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet via web conference on June 13, 2017, from 10:00 
a.m. to 1:00 p.m. EDT.
    The Board will meet in open session to provide updates on the 
Mandatory Guidelines for Federal Workplace Drug Testing Program, and 
updates from our federal partners in the Department of Transportation, 
Nuclear Regulatory Commission, Department of Defense, and the National 
Laboratory Certification Program (NLCP).
    The public is invited to listen via web conference only. There will 
be no on-site attendance available. Due to the limited call-in 
capacity, registration is requested. Public comments are welcome. If 
you intend to provide public comments, please register and provide a 
summary of your comments to the contact listed below. The Division of 
Workplace Programs will review public comments to ensure that they 
address the topics scheduled to be discussed during the meeting and 
adhere to the meeting's established time limits for public comments. To 
obtain the web conference call-in numbers and access codes, 
registration can be completed online at http://snacregister.samhsa.gov/MeetingList.aspx.
    Meeting information, materials (presentations, meeting summary, 
transcripts), and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees Web site, http://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Dates/Time/Type: June 13, 2017, from 10:00 a.m. to 1:00 p.m., EDT: 
OPEN.
    Place: Parklawn Building, Room 5A03, 5600 Fishers Lane, Rockville, 
Maryland 20857.
    Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers 
Lane, Room 16N02B, Rockville, Maryland 20857.
    Telephone: 240-276-2600.
    Fax: 240-276-2610.
    Email: [email protected].

Brian Makela,
Chemist, Substance Abuse and Mental Health Services Administration.
[FR Doc. 2017-10989 Filed 5-26-17; 8:45 am]
BILLING CODE 4162-20-P